Indian pharma companies’ revenue to grow 7-9 pc in FY26 amidst US market risks: Report
New Delhi, Sep 18 (IANS) The Indian pharmaceutical sector is expected to achieve 7-9 per cent revenue growth in FY 2026, driven by strong domestic and European demand, despite a significant slowdown in its US market, a report said on Thursday.